COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

(2020) Steven P. Treon et al.   BLOOD

Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes

(2020) James T. England et al.   BLOOD REVIEWS

Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies

(2020) Fernando Martín‐Moro et al.   BRITISH JOURNAL OF HAEMATOLOGY

Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection

(2020) Rongqing Zhao et al.   CLINICAL INFECTIOUS DISEASES

Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China

(2020) Wen-hua Liang et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical and immunological features of severe and moderate coronavirus disease 2019

(2020) Guang Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study

(2020) Jianbo Tian et al.   LANCET ONCOLOGY

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

(2020) Kunyu Yang et al.   LANCET ONCOLOGY

CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report

(2020) Tycho Baumann et al.   LEUKEMIA

COVID-19 in persons with haematological cancers

(2020) Wenjuan He et al.   LEUKEMIA

COVID-19 in a patient with chronic lymphocytic leukaemia

(2020) Xiang-Hong Jin et al.   Lancet Haematology

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report

(2020) Antonio Cuneo et al.   BLOOD

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

(2020) Mark Roschewski et al.   Science Immunology

Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections

(2019) Rossana Maffei et al.   BLOOD REVIEWS

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

(2018) Michael Hallek et al.   BLOOD

Perturbation of the normal immune system in patients with CLL

(2015) F. Forconi et al.   BLOOD

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

(2012) J. C. Riches et al.   BLOOD